There is increasing evidence that Androgen Receptor (AR) expression has prognostic
usefulness in Triple negative breast cancer (TNBC), where tumors that lack AR expression …

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center,
Houston, TX, USA and anastrozole was closed due to poor accrual. Further research is …

Kornegoor R, Verschuur‐Maes AHJ, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ,
Hinrichs B & van Diest PJ (2012) Histopathology Immunophenotyping of male breast cancer …

Purpose Male breast cancer (MBC) is a rare cancer entity, with mutations in BRCA1 and
BRCA2 genes accounting for~ 10% of patients. Multiple-gene sequencing has already …

Purpose Breast cancer (BC) in males accounts for< 0.5% of all male cancer diagnoses and~
1% of all BCs in the United States. We sought to describe clinicopathologic characteristics …

Background: Androgen receptor (AR) has emerged as a significant favorable prognostic
indicator in estrogen receptor expressing (ER+) breast cancer (BCa); however, its clinical …

Background Male breast cancer (MBC) commonly expresses hormone receptors and there
is anecdotal evidence of disease responsivity to aromatase inhibitors in the metastatic …

Objective We aimed to describe the differences in clinicopathological characteristics and
overall survival (OS) between male and female breast cancer patients, and to develop a …

BACKGROUND In contrast to female breast carcinoma, information regarding the
prevalence and prognostic information of new molecular markers is limited in male breast …

Breast cancer in men is a rare disease, accounting for∼ 1% of all breast cancer cases.
Although the epidemiologic literature regarding female breast cancer is extensive, relatively …